Science
New European database to support environmental risk assessment of human pharmaceuticals
Publication: Phys.org - latest science and technology news stories
Author: Not available in collected metadata
Source published: 05/11/2026, 17:40:12 UTC
Briefing created: 05/11/2026, 17:56:01 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 05/11/2026, 17:55:25 UTC.
Briefings
The PREMIER project launched a publicly accessible, free database for European environmental risk assessment of human pharmaceuticals, developed by a consortium including Radboud University and international pharmaceutical companies. The initiative aims to support regulatory decisions by providing standardized data on drug environmental fate. Key facts include the project's public-private nature and the immediate availability of the data for researchers and policymakers.
Key points
- The PREMIER project is a public-private consortium comprising research organizations like Radboud University and international pharmaceutical companies.
- The database is publicly accessible and free of charge, with data specifically built to meet key user requirements for environmental risk assessment.
Context
This initiative addresses the need for standardized data to support environmental risk assessment of human pharmaceuticals across Europe, facilitating better regulatory decisions and environmental protection strategies.
Limitations
The evidence indicates the database is publicly accessible and free of charge, but specific data content, update frequency, and access protocols are not detailed in the provided source.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 05/11/2026, 17:56:01 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeiezjq3qfmpxn5l2za4765g4dyj5p53w5hggevjeyf2nz6owktukaa